Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy.
暂无分享,去创建一个
F. Pontén | A. Asplund | K. Magnusson | S. Strömberg | M. Bergqvist | M. Uhlén | E. Blomquist | S. Ekman | P. Jonnalagadda | G. Holgersson | S. Bergström | J. Reizenstein | B. Lödén | Karin Hellström | Arne Linder | M. Liljeholm
[1] H. Becher,et al. Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes , 2009, International journal of cancer.
[2] T. Nielsen,et al. Tissue microarrays in clinical oncology. , 2008, Seminars in radiation oncology.
[3] A. Georgiou,et al. The Role of Host Immune Response and Apoptosis in Patients with Laryngeal Squamous Cell Carcinoma , 2007, ORL.
[4] E. Korobowicz,et al. An immunohistochemical study of cyclin D1 protein expression in laryngeal squamous cell carcinoma , 2007, Acta oto-laryngologica.
[5] F. Pontén,et al. Analysis of Protein Expression in Cell Microarrays: A Tool for Antibody-based Proteomics , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[6] C. Petito,et al. Expression of the Antiapoptotic Proteins Clusterin and Bcl-2 in Laryngeal Squamous Cell Carcinomas , 2006, Tumor Biology.
[7] A. Lazaris,et al. Cyclin D1 Protein Tissue Detection in Laryngeal Cancer , 2005, ORL.
[8] Erik K. Malm,et al. A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics* , 2005, Molecular & Cellular Proteomics.
[9] Chengzhang Yang,et al. [The expression of ki-67, topoIIalpha in laryngeal squamous cell carcinoma]. , 2005, Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology.
[10] J. Jacobs,et al. Prognostic significance of G1 cell-cycle inhibitors in early laryngeal cancer. , 2005, American journal of otolaryngology.
[11] George Fountzilas,et al. Clinical and molecular prognostic factors in operable laryngeal cancer , 2005, European Archives of Oto-Rhino-Laryngology and Head & Neck.
[12] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[13] J. Overgaard,et al. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma , 2005, Acta oncologica.
[14] G. Pruneri,et al. Prognostic Significance of P27 and Cyclin D1 Co-Expression in Laryngeal Squamous Cell Carcinoma: Possible Target for Novel Therapeutic Strategies , 2004, Journal of chemotherapy.
[15] J. Simpson,et al. Management of Stage IV Glottic Carcinoma: Therapeutic Outcomes , 2004, The Laryngoscope.
[16] Ülkü Öner,et al. Prognostic significance of Ki-67 expression for patients with laryngeal squamous cell carcinoma primarily treated by total laryngectomy , 2004, European Archives of Oto-Rhino-Laryngology and Head & Neck.
[17] L. Puzzo,et al. p53 overexpression on the resection margins as a marker of local recurrence in glottic T1a carcinoma. , 2003, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.
[18] K. Franssila,et al. Cyclin A and Ki-67 expression as predictors for locoregional recurrence and outcome in laryngeal cancer patients treated with surgery and postoperative radiotherapy. , 2003, International journal of radiation oncology, biology, physics.
[19] R. Rezola,et al. p53 and Cyclin D1 as Prognostic Factors in Squamous Cell Carcinoma of the Larynx , 2003, The Laryngoscope.
[20] C. la Vecchia,et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case–control study , 2002, Cancer Causes & Control.
[21] H. Baloglu,et al. Significance of p53 and bcl-2 Immunoexpression in the Prognosis of Laryngeal Squamous Cell Carcinoma , 2002, The Journal of international medical research.
[22] Y. Dong,et al. Cyclin D1‐CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas , 2001, International journal of cancer.
[23] D. Caldarelli,et al. Prognostic significance of Bcl‐2 and p53 expression in advanced laryngeal squamous cell carcinoma , 2001, Head & neck.
[24] L. Wilson,et al. Prognostic significance of cyclin D1 protein levels in early‐stage larynx cancer treated with primary radiation , 2000, International journal of cancer.
[25] Bruce H. Haughey,et al. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation. , 1999 .
[26] K. Chao,et al. Stage I (t1 N0 M0) squamous cell carcinoma of the laryngeal glottis: Therapeutic results and voice preservation , 1999, Head & neck.
[27] K. Chao,et al. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery , 1999, Head & neck.
[28] J. Jiricny. Replication errors: cha(lle)nging the genome , 1998, The EMBO journal.
[29] G. Pruneri,et al. Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[31] H. Pai,et al. Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy. , 1998, International journal of radiation oncology, biology, physics.
[32] D M Parkin,et al. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. , 1997, European journal of cancer.
[33] J. Eshleman,et al. Mismatch repair defects in human carcinogenesis. , 1996, Human molecular genetics.
[34] Robin J. Leach,et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.
[35] C. Terhaard,et al. Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni- and multivariate analysis. , 1991, International journal of radiation oncology, biology, physics.
[36] B. Cummings,et al. T3 glottic cancer: an analysis of dose time-volume factors. , 1981, International journal of radiation oncology, biology, physics.
[37] A. Jemal,et al. Global Cancer Statistics , 2011 .
[38] M. Zabel,et al. Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer. , 2007, Anticancer research.
[39] E. Pınar,et al. [Expression of Ki-67 and p53 in laryngeal squamous cell carcinomas]. , 2005, Kulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat.
[40] S. Fisher,et al. P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. , 2000, International journal of radiation oncology, biology, physics.
[41] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[42] B. Cummings,et al. T2 glottic cancer: an analysis of dose-time-volume factors. , 1981, International journal of radiation oncology, biology, physics.